Pioneering diagnostics
E.g., 28/11/2015
E.g., 28/11/2015

bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection  jointly developed with BioFire

New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology

04 November, 2015

bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of GENE-UP®, its new PCR-based molecular diagnostic system for the detection of microorganisms (bacteria and viruses). This platform enables the microbiological control of food, raw...

bioMérieux – Business review for the nine months ended September 30, 2015

22 October, 2015

  •  Robust growth in nine-month sales:
    •  Sales reached €1,412 million...

BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel continuing its extremely favorable business momentum

FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform

09 October, 2015

Marcy l’Étoile, France – October 9, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced, as issued in a press release by the U.S. Food and Drug Administration (FDA) yesterday, that BioFire Diagnostics, its molecular biology...

BioFire Defense, a bioMérieux company, receives Emergency Use Assessment and Listing for FilmArray® Ebola Test by the World Health Organization

24 September, 2015

Marcy l’Etoile (France) – September 24, 2015 – BioFire Defense, LLC of Salt Lake City, UT announces that its FilmArray® Ebola test (BioThreat-E test1) has received Emergency Use Assessment and...

bioMérieux – First-Half 2015 Results

31 August, 2015

  • Strong growth in business
    • €933 million in sales
    • ...

bioMérieux receives FDA 510(k) clearance for VIDAS® 3, the new generation of VIDAS®

Innovative VIDAS® immunoassays system designed to answer clinical laboratories needs for automation, traceability, quality and optimized workflow

27 July, 2015

Marcy l'Etoile, France, July 27, 2015 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, received FDA 510(k) clearance. This instrument...

First-Half 2015 Business Review

17 July, 2015

  • Strong growth in business 
    • ...

Global experts engage in the fight against antimicrobial resistance during the World HAI/Resistance Forum organized by bioMérieux

For the Forum’s 5th edition, bioMérieux commits to support a global educational project on the fight against antimicrobial resistance recognized as a major global public health threat.

22 June, 2015

Marcy l’Etoile (France) – June 22, 2015 – Over 70 world renowned experts in the field of antimicrobial resistance met in Annecy for the 5th edition of the World HAI/Resistance Forum, sponsored by bioMérieux, a world leader in the field of in vitro...

bioMérieux - First-Quarter 2015 Business Review

23 April, 2015

Strong growth in sales

  • €448 million in sales

  • Up 20.8% as reported

  • ...

BioFire Submits De Novo Application to FDA for FilmArray® Meningitis/Encephalitis Panel

14 April, 2015

Marcy l’Etoile, France - April 14, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its molecular biology affiliate, has submitted a de novo classification request to the U.S. Food and Drug...